Eladio Viñuela

Title: Eladio Viñuela: Innovator in Vaccine Technology

Introduction

Eladio Viñuela is a prominent inventor based in Madrid, Spain. He is known for his significant contributions to the field of vaccine technology, particularly through his innovative use of recombinant swine poxvirus.

Latest Patents

Viñuela holds a patent for the "Use of recombinant swine poxvirus as a live vaccine vector." This invention provides a recombinant swinepox virus vector that contains a heterologous nucleotide sequence encoding a protein from a selected pathogen. This sequence is inserted into, or replaces, all or a portion of a swinepox virus gene that is not essential for the virus's replication in a host cell. Additionally, the patent includes a recombinant SPV vector into which a pseudorabies antigen is inserted within the TK gene. This development is useful in diagnostic, therapeutic, and prophylactic compositions.

Career Highlights

Eladio Viñuela is affiliated with the University of Florida Research Foundation Inc., where he continues to advance his research in vaccine development. His work has garnered attention for its potential applications in improving vaccine efficacy and safety.

Collaborations

Viñuela has collaborated with notable colleagues, including Richard W. Moyer and E. P. J. Gibbs. These partnerships have contributed to the advancement of his research and the development of innovative solutions in the field of immunology.

Conclusion

Eladio Viñuela's work exemplifies the intersection of innovation and public health. His contributions to vaccine technology are paving the way for new approaches to disease prevention.